List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 377 studies with search of:   Ukraine
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma
Condition: Malignant Melanoma
Intervention: Drug: HSPPC-96 or Oncophage
2 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
3 Completed A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients
Condition: Overactive Bladder
Intervention: Drug: fesoterodine fumarate
4 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
5 Completed Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients
Condition: Parkinson Disease
Interventions: Drug: Pramipexol Extended Release;   Drug: Pramipexol Immediate Release;   Drug: Placebo
6 Recruiting Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
7 Recruiting LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Conditions: ErbB2 (HER2) Amplified Gastric;   Esophageal;   or Gastro-Esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.
Intervention: Drug: Lapatinib
8 Active, not recruiting Cetuximab Combined With Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
Condition: EGFR-Expressing Metastatic Colorectal Cancer
Interventions: Drug: Cetuximab, 5-Fluorouracil, Folinic acid, Irinotecan;   Drug: 5-Fluorouracil, Folinic acid, Irinotecan
9 Recruiting Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
Conditions: Osteoarthritis;   Arthritis, Rheumatoid
Interventions: Drug: Celecoxib;   Drug: Diclofenac + Omeprazole
10 Completed A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Certolizumab Pegol
11 Recruiting Study of Apixaban for the Prevention of Thrombosis-Related Events in Patients With Acute Medical Illness
Conditions: Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Apixaban;   Drug: Enoxaparin
12 Recruiting Adjunctive Zonisamide in Primary Generalized Tonic Clonic Seizures
Condition: Epilepsy
Interventions: Drug: Zonisamide;   Drug: Placebo
13 Not yet recruiting The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Conditions: Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease;   CV Risk
Interventions: Drug: Darapladib;   Drug: Placebo
14 Recruiting Study of LJP 394 in Lupus Patients With History of Renal Disease
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: abetimus sodium (LJP 394) and/or placebo solution;   Drug: abetimus sodium (LJP 394);   Drug: Phosphate-buffered saline
15 Active, not recruiting Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
Condition: Bacterial Pneumonia
Interventions: Drug: ceftaroline;   Drug: ceftriaxone
16 Recruiting EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients
Condition: Breast Neoplasms
Interventions: Drug: EndoTAG-1 + paclitaxel;   Drug: EndoTAG-1;   Drug: Paclitaxel
17 Completed PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia
Condition: Neuralgia, Postherpetic
Interventions: Drug: PH-797804;   Drug: Placebo
18 Completed Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Drug: Mecamylamine
19 Active, not recruiting A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: aleglitazar;   Drug: Actos
20 Recruiting Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia
Condition: Bacterial Pneumonia
Interventions: Drug: ceftaroline;   Drug: ceftriaxone

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services